Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.

Annales Universitatis Mariae Curie-Skłodowska. Sectio D: Medicina

Volumn 58, Issue 1, 2003, Pages 248-253

  Bojarska Szmygin, Anna ^a   Janicki, Krzysztof ^a   Pietura, Radosław ^a   Janicka, Lucyna ^a  

^a Cardinal Stefan Wyszynski Regional Specialised Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; AUTOANTIBODY; BIOLOGICAL MARKER; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; THYROIDECTOMY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTITHYROID AGENTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; METHIMAZOLE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, THYROTROPIN; SENSITIVITY AND SPECIFICITY; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 7444262385     PISSN: 00662240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)